Literature DB >> 17704000

Apoptosis in the skeletal muscle of untreated children with juvenile dermatomyositis: impact of duration of untreated disease.

Yongdong Zhao1, Tamara O Fedczyna, Violet McVicker, Jan Caliendo, Honglin Li, Lauren M Pachman.   

Abstract

Juvenile dermatomyositis (JDM) is the most common myopathy in children with characteristic skin rash and muscle weakness, in which longer duration of untreated disease was associated with less muscle weakness. The duration of untreated inflammation may alter the apoptotic pathways involved in skeletal muscle damage. Diagnostic muscle biopsies from 14 untreated patients were stained for apoptosis markers. TUNEL-positive nuclei and caspase 3 were detected within the laminin layer, indicating apoptosis of skeletal muscle nuclei. Untreated JDM disease duration greater than 2 months ("long"), was associated with higher Fas-positive cell counts in the perivascular region compared with the "short" disease duration group, 2 months or less. Within the "long" duration group, higher Fas-positive cell counts were positively associated with increased TUNEL-positive nuclei and caspase 3. We conclude that the duration of untreated disease (chronic inflammation) influences the mode of continuing cell damage and death in children with JDM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17704000      PMCID: PMC2219965          DOI: 10.1016/j.clim.2007.06.011

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  32 in total

Review 1.  Autoimmune lymphoproliferative syndrome, a disorder of apoptosis.

Authors:  C E Jackson; J M Puck
Journal:  Curr Opin Pediatr       Date:  1999-12       Impact factor: 2.856

2.  History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry.

Authors:  Lauren M Pachman; Rebecca Lipton; Rosalind Ramsey-Goldman; Eli Shamiyeh; Kathy Abbott; Eduardo P Mendez; Alan Dyer; Deborah Mc Curdy; Larry Vogler; Ann Reed; Gail Cawkwell; Lawrence Zemel; Christy Sandborg; Rafael Rivas-Chacon; Christine Hom; Norman Ilowite; Abraham Gedalia; Jonathan Gitlin; Michael Borzy
Journal:  Arthritis Rheum       Date:  2005-04-15

3.  Nuclear translocation of EndoG at the initiation of disuse muscle atrophy and apoptosis is specific to myonuclei.

Authors:  Esther E Dupont-Versteegden; Beau A Strotman; Cathy M Gurley; Dana Gaddy; Micheal Knox; James D Fluckey; Charlotte A Peterson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-07-27       Impact factor: 3.619

Review 4.  Apoptosis control by death and decoy receptors.

Authors:  A Ashkenazi; V M Dixit
Journal:  Curr Opin Cell Biol       Date:  1999-04       Impact factor: 8.382

5.  The inhibition of apoptosis in myositis and in normal muscle cells.

Authors:  K Nagaraju; L Casciola-Rosen; A Rosen; C Thompson; L Loeffler; T Parker; C Danning; P J Rochon; J Gillespie; P Plotz
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

6.  RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis.

Authors:  Kelly A Rouster-Stevens; Craig B Langman; Heather E Price; Roopa Seshadri; Richard M Shore; Kathy Abbott; Lauren M Pachman
Journal:  Arthritis Rheum       Date:  2007-03

7.  TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications.

Authors:  L M Pachman; M R Liotta-Davis; D K Hong; T R Kinsella; E P Mendez; J M Kinder; E H Chen
Journal:  Arthritis Rheum       Date:  2000-10

8.  Fas and Fas ligand interaction induces apoptosis in inflammatory myopathies: CD4+ T cells cause muscle cell injury directly in polymyositis.

Authors:  T Sugiura; Y Murakawa; A Nagai; M Kondo; S Kobayashi
Journal:  Arthritis Rheum       Date:  1999-02

9.  Duration of illness is an important variable for untreated children with juvenile dermatomyositis.

Authors:  Lauren M Pachman; Kathy Abbott; James M Sinacore; Lisa Amoruso; Alan Dyer; Rebecca Lipton; Norman Ilowite; Christine Hom; Gail Cawkwell; Andrew White; Rafael Rivas-Chacon; Yukiko Kimura; Linda Ray; Rosalind Ramsey-Goldman
Journal:  J Pediatr       Date:  2006-02       Impact factor: 4.406

10.  TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque.

Authors:  Kayoko Sato; Alexander Niessner; Stephen L Kopecky; Robert L Frye; Jörg J Goronzy; Cornelia M Weyand
Journal:  J Exp Med       Date:  2006-01-17       Impact factor: 14.307

View more
  11 in total

1.  Further considerations on in vitro skeletal muscle cell death.

Authors:  Michela Battistelli; Sara Salucci; Sabrina Burattini; Elisabetta Falcieri
Journal:  Muscles Ligaments Tendons J       Date:  2014-02-24

2.  Muscle-derived TRAIL negatively regulates myogenic differentiation.

Authors:  Dongwook Kim; Nilmani Singh; Rachel J Waldemer-Streyer; Mee-Sup Yoon; Jie Chen
Journal:  Exp Cell Res       Date:  2020-07-06       Impact factor: 3.905

Review 3.  Advances in Juvenile Dermatomyositis: Myositis Specific Antibodies Aid in Understanding Disease Heterogeneity.

Authors:  Lauren M Pachman; Amer M Khojah
Journal:  J Pediatr       Date:  2018-04       Impact factor: 4.406

4.  The role of TRAIL in mediating autophagy in myositis skeletal muscle: a potential nonimmune mechanism of muscle damage.

Authors:  Heather M Alger; Nina Raben; Emidio Pistilli; Dwight L Francia; Rashmi Rawat; Derese Getnet; Svetlana Ghimbovschi; Yi-Wen Chen; Ingrid E Lundberg; Kanneboyina Nagaraju
Journal:  Arthritis Rheum       Date:  2011-11

Review 5.  Cell death, clearance and immunity in the skeletal muscle.

Authors:  C Sciorati; E Rigamonti; A A Manfredi; P Rovere-Querini
Journal:  Cell Death Differ       Date:  2016-02-12       Impact factor: 15.828

6.  Serum-soluble TRAIL: a potential biomarker for disease activity in myositis patients.

Authors:  Hang Zhou; Yunchao Wang; Kuo Bi; Haiyu Qi; Shuju Song; Mingzhu Zhou; Letian Chen; Guochun Wang; Ting Duan
Journal:  Clin Rheumatol       Date:  2019-01-15       Impact factor: 2.980

7.  Characterization of dystrophic calcification induced in mice by cardiotoxin.

Authors:  Yongdong Zhao; Annette L Urganus; Lyudmila Spevak; Sheela Shrestha; Stephen B Doty; Adele L Boskey; Lauren M Pachman
Journal:  Calcif Tissue Int       Date:  2009-08-20       Impact factor: 4.333

8.  Role of VEGF and VEGFR2 Receptor in Reversal of ALS-CSF Induced Degeneration of NSC-34 Motor Neuron Cell Line.

Authors:  K Vijayalakshmi; Piyush Ostwal; R Sumitha; S Shruthi; Anu Mary Varghese; Poojashree Mishra; S Gowri Manohari; B C Sagar; T N Sathyaprabha; A Nalini; T R Raju; Phalguni Anand Alladi
Journal:  Mol Neurobiol       Date:  2014-06-01       Impact factor: 5.590

9.  Juvenile dermatomyositis calcifications selectively displayed markers of bone formation.

Authors:  Annette L Urganus; Yong-Dong Zhao; Lauren M Pachman
Journal:  Arthritis Rheum       Date:  2009-04-15

10.  Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis.

Authors:  Yi-Wen Chen; Rongye Shi; Nicholas Geraci; Sheela Shrestha; Heather Gordish-Dressman; Lauren M Pachman
Journal:  BMC Immunol       Date:  2008-07-31       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.